Levels of Evidence | GenomeWeb

Levels of Evidence

As more and more genetic variants are linked to disease risk, Geoffrey Ginsburg, director of genomic medicine at Duke University, argues in Nature that "there needs to be an efficient way to evaluate whether genetic information leads to better health care."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.